Teleflex Incorporated (NYSE:TFX) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) have been assigned an average rating of "Hold" from the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $164.63.

Several research analysts recently weighed in on the stock. Wells Fargo & Company dropped their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, May 2nd. Royal Bank Of Canada dropped their price objective on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a report on Friday, May 2nd. Truist Financial dropped their price objective on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Morgan Stanley dropped their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Monday, May 5th. Finally, Mizuho set a $155.00 price objective on shares of Teleflex in a report on Wednesday, April 16th.

Teleflex Stock Down 2.9%

NYSE TFX opened at $116.46 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.28 and a quick ratio of 1.32. The stock has a market capitalization of $5.15 billion, a PE ratio of 36.74, a PEG ratio of 1.82 and a beta of 1.08. Teleflex has a 1 year low of $115.94 and a 1 year high of $249.91. The business's 50-day moving average is $121.71 and its 200 day moving average is $143.52.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.88 by $0.03. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The business had revenue of $700.67 million for the quarter, compared to analysts' expectations of $699.37 million. During the same period in the previous year, the firm posted $3.21 EPS. The business's revenue was down 5.0% on a year-over-year basis. Sell-side analysts forecast that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.17%. Teleflex's payout ratio is 42.90%.

Institutional Trading of Teleflex

Several hedge funds have recently made changes to their positions in TFX. T. Rowe Price Investment Management Inc. boosted its position in shares of Teleflex by 0.7% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company's stock worth $859,095,000 after purchasing an additional 43,642 shares during the period. Geode Capital Management LLC boosted its position in shares of Teleflex by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after purchasing an additional 8,307 shares during the period. Invesco Ltd. boosted its position in shares of Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock worth $190,188,000 after purchasing an additional 347,003 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Teleflex by 69.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock worth $119,927,000 after purchasing an additional 355,720 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Teleflex by 38.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock worth $105,102,000 after purchasing an additional 162,950 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.